OLMA stock news
This page provides real-time market news, earnings updates, and company announcements related to Olema Pharmaceuticals, Inc. (OLMA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-08 09:09 EST
Olema’s Proposal Dampens Hopes for Trial, Sparks Decline Due to Dilution Concerns
Bitget-RWA2025-11-19 12:28:14
Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating
Finviz2026-02-16 17:24:49
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-19 21:36:38
Citi, Stifel Bullish on Olema (OLMA) Despite COO Departure
Finviz2026-02-27 21:09:36
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-03 21:33:40
Why Is Olema Pharmaceuticals Stock Dropping On Monday?
Finviz2026-03-09 16:25:00
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-16 11:03:46
Olema Pharmaceuticals Inc (OLMA) announced that patient recruitment for the Phase 1 clinical study of its candidate drug OP-3136 is underway.
老虎证券2026-03-16 11:46:05
Biotech shares surge almost 300% as $68.7 million investment backs breast cancer treatment aiming for 2027 debut
101 finance2026-03-16 23:12:35
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Finviz2026-03-17 20:33:51
Olema Pharmaceuticals (OLMA) Drops 33.4% Over Past Month, Reasons Suggest a Potential Turnaround Ahead
101 finance2026-03-18 14:40:09
Olema Shares Surge 242%—Does a $122 Million Stake Indicate Further Growth Ahead?
101 finance2026-03-22 16:39:49
Paradigm's $122M Olema Bet: Buy the Dip or Setup for Fall 2026 Data Reset?
101 finance2026-03-22 16:54:52
Olema's $122M in Institutional Support Hinges on an All-or-Nothing Clinical Trial Result — $1.2B Valuation Leaves No Room for Error
101 finance2026-03-22 17:42:57
OLMA Surges 12% in Pre-Market — But No Catalyst in Sight
101 finance2026-03-23 12:48:50
Orla Mining: DCF Suggests 44% Price-to-Intrinsic Value Gap Amid Expansion Push
101 finance2026-04-02 11:57:36
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-02 20:33:45
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-03 21:33:40
Why Is Olema Pharmaceuticals Stock Dropping On Monday?
Finviz2026-03-09 16:25:00
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-16 11:03:46
Olema Pharmaceuticals Inc (OLMA) announced that patient recruitment for the Phase 1 clinical study of its candidate drug OP-3136 is underway.
老虎证券2026-03-16 11:46:05
Biotech shares surge almost 300% as $68.7 million investment backs breast cancer treatment aiming for 2027 debut
101 finance2026-03-16 23:12:35
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Finviz2026-03-17 20:33:51
Olema Pharmaceuticals (OLMA) Drops 33.4% Over Past Month, Reasons Suggest a Potential Turnaround Ahead
101 finance2026-03-18 14:40:09
Olema Shares Surge 242%—Does a $122 Million Stake Indicate Further Growth Ahead?
101 finance2026-03-22 16:39:49
Paradigm's $122M Olema Bet: Buy the Dip or Setup for Fall 2026 Data Reset?
101 finance2026-03-22 16:54:52
Olema's $122M in Institutional Support Hinges on an All-or-Nothing Clinical Trial Result — $1.2B Valuation Leaves No Room for Error
101 finance2026-03-22 17:42:57
OLMA Surges 12% in Pre-Market — But No Catalyst in Sight
101 finance2026-03-23 12:48:50
Orla Mining: DCF Suggests 44% Price-to-Intrinsic Value Gap Amid Expansion Push
101 finance2026-04-02 11:57:36
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-02 20:33:45
OLMA stock chart
OLMA stock detailsOLMA stock price change
On the last trading day, OLMA stock closed at 15.17 USD, with a price change of 0.73% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more